Publication | Closed Access

BOXIT—A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)

UrologyTransitional Cell CarcinomaGenitourinary CancerMedicineClinical TrialsStandard TreatmentCancer TreatmentOncologyRadiation OncologyCancer ResearchMolecular OncologyHealth Sciences